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Abstract: OBJECTIVE: There are no instruments available to comprehensively assess health-related
quality of life (HRQoL) in chronic otitis media (COM) in Italian-speaking countries. The Zurich chronic
middle ear inventory (ZCMEI-21) is a well-established instrument for the assessment of HRQoL in COM.
The objective of this study was to translate and cross-culturally adapt the ZCMEI-21 into Italian and
validate this questionnaire for measuring HRQoL in patients with COM. STUDY DESIGN: Prospective
multicenter study. SETTING: Three University hospitals (northern Italy, central Italy, southern Italy).
PATIENTS: Adult patients suffering from COM (n = 128). INTERVENTION: Following international
guidelines, the ZCMEI-21 was translated into Italian (ZCMEI-21-It). Validation was performed by psy-
chometric test statistics. Moreover, ZCMEI-21-It total and subscale scores were compared and correlated
with 1) the scores of the original validation study, 2) to a question that directly addresses HRQoL, and
3) to the scores of the EQ-5D-5L, a generic questionnaire assessing HRQoL. RESULTS: From three study
centers, a total of 128 patients with COM were included. Cronbach’s ฀ was 0.86 indicating a high relia-
bility. Between the ZCMEI-21-It total score and the question that directly addresses HRQoL, we found
a strong correlation (r = 0.62, p < 0.0001). Between the ZCMEI-21-It total score and the EQ-5D-5L
scores, we expectedly found moderate correlations (descriptive system score: r = 0.39, p < 0.0001; vi-
sual analog scale: r = 0.30, p = 0.008). CONCLUSION: We translated the ZCMEI-21 questionnaire
into Italian and validated the ZCMEI-21-It in a prospective multicenter study. The ZCMEI-21-It is the
first instrument that comprehensively assesses relevant dimensions of HRQoL in Italian-speaking patients
affected by COM.
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Objective: There are no instruments available to comprehen-
sively assess health-related quality of life (HRQoL) in
chronic otitis media (COM) in Italian-speaking countries.
The Zurich chronic middle ear inventory (ZCMEI-21) is a
well-established instrument for the assessment of HRQoL in
COM. The objective of this study was to translate and cross-
culturally adapt the ZCMEI-21 into Italian and validate this
questionnaire for measuring HRQoL in patients with COM.
Study Design: Prospective multicenter study.
Setting: Three University hospitals (northern Italy, central
Italy, southern Italy).
Patients: Adult patients suffering from COM (n¼ 128).
Intervention: Following international guidelines, the
ZCMEI-21 was translated into Italian (ZCMEI-21-It). Vali-
dation was performed by psychometric test statistics. More-
over, ZCMEI-21-It total and subscale scores were compared
and correlated with 1) the scores of the original validation
study, 2) to a question that directly addresses HRQoL, and
3) to the scores of the EQ-5D-5L, a generic questionnaire
assessing HRQoL.
Results: From three study centers, a total of 128 patients
with COM were included. Cronbach’s a was 0.86 indicating
a high reliability. Between the ZCMEI-21-It total score and
the question that directly addresses HRQoL, we found a
strong correlation (r¼ 0.62, p< 0.0001). Between the
ZCMEI-21-It total score and the EQ-5D-5L scores, we
expectedly found moderate correlations (descriptive system
score: r¼ 0.39, p< 0.0001; visual analog scale: r¼ 0.30,
p¼ 0.008).
Conclusion: We translated the ZCMEI-21 questionnaire into
Italian and validated the ZCMEI-21-It in a prospective
multicenter study. The ZCMEI-21-It is the first instrument
that comprehensively assesses relevant dimensions of
HRQoL in Italian-speaking patients affected by COM.
Key Words: Cholesteatoma patient-reported outcome
measure—Chronic otitis media—Health-related quality of
life—Italian—ZCMEI-21.
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Chronic (suppurative) otitis media (COM) is a chronic
inflammation of the middle ear and mastoid mucosa
characterized by a tympanic perforation lasting > 6 to
12 weeks which usually leads to a persistent or recurrent
discharge from the middle ear (1). Chronic otitis media is
a leading cause of health care visits, antibiotic prescrip-
tions, and surgery (2,3); it causes preventable conductive
hearing loss and increases the risk for permanent senso-
rineural hearing loss (4–6). The global incidence rate of
COM is estimated at 4.8 new episodes per 1,000 people,
with a total annual number of cases of 31 million (35). A
World Health Organization report suggests that 65 to 350
million individuals are suffering from COM globally (7).
In the assessment of COM and its treatment, patient-
reported outcomes (PROs) are gaining increasing impor-
tance and are often used in addition to objective outcome
measures, such as audiometric results (8). In contrast to
objective outcomes, PROs represent a subjective assess-
ment of the patient’s perspective, which may not be
reflected by objective outcomes. One of the most impor-
tant PROs is health-related quality of life (HRQoL) (9),
which is assessed by patient-reported outcomes measures
(PROMs), usually in the form of questionnaires completed
by the patient. Comparing PROM scores before and after
an intervention can be used in the outcome analysis of an
intervention, to evaluate its possible effectiveness (10). As
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specific symptoms and their consequences impair HRQoL
in COM, generic questionnaires generally are not well
suited for COM due to their lack of sensitivity to reliably
detect relevant aspects of HRQoL (6,11,12). Nonetheless,
several generic questionnaires, especially questionnaires
including a hearing loss domain, have been applied to
specific otologic conditions, e.g., the Hearing Handicap
Inventory or the Health Utilities Index Mark 3 (13,14).
There have been several attempts to assess QoL in adult
COM. To date, five questionnaires have been developed to
assess relevant symptoms and dimensions of HRQoL in
COM: the Chronic Ear Survey (CES; available in English,
Chinese, Korean, and Italian) (15), the English Chronic
Otitis Media 5 (COM-5) (16), the German Chronic Otitis
Media Outcome Test 15 (COMOT-15) (17), the Chronic
Otitis Media Questionnaire 12 (COMQ-12; available in
English, Dutch, and Russian) (18) and the Zurich Chronic
Middle Ear Inventory21 (ZCMEI-21; available inGerman
and Japanese) (19).
To provide a comparable and consistent assessment of
HRQoL in different countries, questionnaires should be
available in multiple languages. Only one of five available
questionnaires for COM was developed and validated in
the Italian-speaking countries, the CES-I questionnaire
(20). The CES-I appears to be a reliable and valid instru-
ment for the investigation of health status among Italian-
speaking patients with COM. However, the CES has
several shortcomings as it does not include vertigo/balance
problems and tinnitus. Moreover, there is no comprehen-
sive assessment of psychosocial problems as there is only
one question, which is exclusively focused on restrictions
due to hearing impairment. Similar shortcomings have
also been pointed out for the COMOT-15 and the COMQ-
12 previously (19): the COMOT-15 is strongly focused on
restriction of activities due to hearing impairment while
the impact of other symptoms is not evaluated. The
COMQ-12 does not assess activity restriction due to
COM, which is also part of the CES, and does not provide
a comprehensive assessment of psychosocial problems.
The ZCMEI-21 is a German-language questionnaire
published in 2016, which provides a comprehensive
assessment of HRQoL in COM patients, especially con-
cerning psychological and social aspects (19). The
ZCMEI-21 questionnaire consists of 21 items grouped
into four subscales: 1) ear signs and symptoms; 2)
hearing; 3) psychosocial impact; and 4) medical resour-
ces. Answers are presented using a 5-point Likert scale
that ranges from 0 (no emotional or physical impact) to 4
(severe emotional or physical impact). The ZCMEI-21
has been recently validated in the Japanese language (21)
and is currently being translated in other languages.
The aim of this multicenter study was to translate and
cross-culturally adapt the ZCMEI-21 into Italian and
validate this new Italian-language questionnaire for mea-
suring HRQoL in patients with COM.
METHODS
This multicenter study included patients recruited in three
large Italian university hospitals. The involved centers were the
Sapienza University of Rome, Policlinico Umberto I (central
Italy), the University of Turin, Ospedale Molinette (northern
Italy), and the Aldo Moro University of Bari (southern Italy).
The inclusion criteria were the diagnosis of COM with or
without cholesteatoma, age  18 years and sufficient Italian
language skills. Further details on the study design are provided
in Figure 1. The study was approved by the local Ethics
Committees and was performed in accordance with the Helsinki
declaration and its amendments. Informed consent was obtained
from all the participants.
Translation of the ZCMEI-21 Into Italian
and Cross-cultural Adaptation
The translation and cross-cultural adaptation of ZCMEI-21
was performed following the Principles of Good Practice for the
Translation and Cultural Adaptation Process for Patient-
Reported Outcomes Measures according to the International
Society for Pharmacoeconomics and Outcomes Research Task
Force (22).
First, two forward translations were performed by two
translation agencies specialized in medical translations. Then,
the two translations were merged into a single translation by
Italian speaking clinicians (ZCMEI-21-It, v1). This version of
ZCMEI-21-It was reviewed by the involved physicians and was
used for a first pilot test (cognitive debriefing 1) in five patients
to detect difficulties in understanding of the questions and
identify items that may not be well suited. The feedback
received by the patients and the clinicians led to several minor
modifications of the initial version. No items were excluded.
The modified questionnaire constituted the second version of
the ZCMEI-21-It (ZCMEI-21-It, v2). Last, a third translation
agency specialized in medical translations carried out a back
translation of the ZCMEI-21-It, v2, into German. After review-
ing the back translation against the original German version, the
ZCMEI-21-It underwent some further minor modifications to
provide a conceptually equivalent Italian translation (ZCMEI-
21-It, v3). Using the latter version, a second cognitive debrief-
ing was performed leading to no additional modifications. At
the end of the translation process, the final version of the
questionnaire (ZCMEI-21-It) was obtained and used for the
validation process (see Supplemental Digital Content 1, http://
links.lww.com/MAO/A730).
Validation Process
The ZMCEI-21-It and the EuroQol five-dimensional ques-
tionnaire (EQ-5D) in its five-level version (EQ-5D-5L) were
administered to COM patients meeting the inclusion criteria
during ambulatory visits.
The EQ-5D-5L is a quickly administered and internationally
recognized instrument aimed to obtain a meaningful description
and measurement of health-related quality of life. The EQ-5D-
5L questionnaire is composed of five questions that are con-
verted to an index value (EQ-5D-5L descriptive system score; it
ranges from 0 to 1, where 1 corresponds to a perfect QoL) and a
visual analogue scale (EQ-5D-5L visual analog scale (VAS),
that ranges from 0 to 100, where 100 corresponds to the best
health state). The five questions in the EQ-5D-5L questionnaire
investigate mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression. The EQ-5D-5L questionnaire has been
validated in the Italian language (23); however, no specific
value set has been developed for Italian. As a replacement, the
UK or the Spanish sets are conventionally used to conduct
evaluations in the Italian population (24–26). In the present
study, a value set for England was used (27).
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As done in the original validation study (19), a general
question was added to directly address HRQoL (question 22,
‘‘My ear illness is worsening my quality of life.... not at all/
mildly/ moderately/severely/very severely’’) for assessment of
the criterion validity.
The minimal sample size considered for this study was 84
patients, based on a subject to item ratio of 4:1 (21 items) (28).
Statistical Analysis
All statistical tests were selected before data collection.
Values are reported as mean  SD or as absolute number
and percentage. Item total-correlation was calculated to assess
if an item correlates with the total score. Internal consistency as
an indicator of reliability was determined by calculation of
Cronbach’s a. Frequency distribution was analyzed by inspec-
tion of the histogram and statistical normality tests (D’Agostino
and Pearson normality test, Shapiro–Wilk normality test; for
both tests, p> 0.05 indicates normal distribution). Criterion
validity was assessed using an additional general question
(question 22) that directly addressed HRQoL. Concurrent
validity was determined by comparing total scores of
ZCMEI-21-It and subscores to the EQ-5D-5L descriptive sys-
tem and VAS scores using Spearman rank correlation and linear
regression analysis including mean prediction intervals. Statis-
tical analyses were performed using IBM SPSS Statistics for
Windows, version 23 (IBM Corp., Armonk, NY) and Prism
(version 7 for Apple Macintosh, GraphPad Software). The
significance level was set to p< 0.05.
RESULTS
One hundred twenty-eight patients were enrolled in the
study and completed the ZCMEI-21-It and the EQ-5D-
5L questionnaires in the three centers involved in this
multicenter study: Sapienza University of Rome, Poli-
clinico Umberto I (48 patients), the University of Turin,
Ospedale Molinette (39 patients), and the Aldo Moro
University of Bari (41 patients). Mean age was
54.1 19.0 years. Chronic otitis media without choles-
teatoma was found in 79 patients (61.7%); cholesteatoma
was present in 49 (38.3%) patients. Chronic otitis media
was unilateral in 105 patients (82%) and bilateral in 23
patients (18%). Detailed demographics and clinical char-
acteristics are shown in Table 1. For all the items, we
found well distributed answers with the full range of
answers used in every question as well as item means
close to two, i.e., the middle value of possible answers
(Table 2). Item-total-correlation of the single items was
assessed as an indicator whether an item correlates well
with the total score. An item-total-correlation of  0.3 is
regarded as a good correlation with the total score thus
being a criterion for an important item. Of the ZMCEI-
21-It, only three items had an item-total-correlation of <
0.3 (Table 2). Yet, all of these items were regarded as







included patients (n = 128)
excluded patients (n = 0)
ZCMEI-21-It, completed by COM patients (n = 128) in 3 study centers
inclusion criteria:
- chronic otitis media
- sufficient Italian language skills








back translation, review of the back 
translation against the original version
(n = 5)
(n = 5)
FIG. 1. Study design for the translation of the ZCMEI-21 into the Italian language questionnaire (ZCMEI-21-It) and validation of the ZCMEI-
21-It. ZCMEI-21 indicates zurich chronic middle ear inventory.
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present study was not set up for an item reduction
process. Therefore, no items were excluded because of
statistical criteria. Internal consistency was determined as
a measure of the questionnaire’s reliability. We found a
Cronbach’s a of 0.86, which indicates a high internal
consistency. Distribution of the answers showed a normal
(Gaussian) distributed as evidenced by inspection of the
histogram (Fig. 2A) and normality tests (D’Agostino and
Pearson normality test, p¼ 0.12; Shapiro–Wilk normal-
ity test, p¼ 0.22). Next, we assessed total scores in
subgroups of the study population to identify any con-
founders affecting the ZCMEI-21-It total score and the
subsequent subscale analysis. We found no significant
differences in the mean total scores neither when patients
were grouped according to having had surgery before nor
according to the COM subtype (Fig. 2, B and C).
Next, we compared ZCMEI-21 total and subscale
scores as well as their correlation with the EQ-5D-5L
descriptive system score between the original validation
study (19) and our translated version, the ZCMEI-21-It.
This comparison showed highly similar values for total
scores, subscale scores, and correlation coefficients
(Table 3). The only exception was correlation of the
ZCMEI-21-It total score and the EQ-5D-5L descriptive
system score. The ZCMEI-21-It total score showed a
strong correlation with the question that directly assesses
HRQoL (question #22; r¼ 0.62, p< 0.0001; Fig. 3A),
indicating a high criterion validity. In contrast, there was
only a low to moderate correlation between the ZCMEI-
21-It total score and the EQ-5D-5L descriptive system
score (r¼ 0.39, p< 0.0001) and the EQ-5D-5L VAS
(r¼ 0.30, p¼ 0.008). Moreover, the ZCMEI-21-It sub-
scale scores were correlated to the EQ-5D-5L descriptive
system and VAS scores. The subscale score for ‘‘ear
signs and symptoms’’ was weakly to moderately corre-
lated to the EQ-5D-5L scores (Fig. 4, A and B; to EQ-5D-
5L descriptive system score: r¼ 0.43, p< 0.0001; to EQ-
5D-5L VAS: r¼ 0.21, p¼ 0.02). No significant correla-
tion was found between the subscale score for ‘‘hearing’’
and the EQ-5D-5L scores (Fig. 4, C and D; to EQ-5D-5L
descriptive system score: p¼ 0.62; to EQ-5D-5L VAS:
r¼ 0.57). Last, a significant but moderate correlation was
found between the subscale score for ‘‘psychosocial
impact’’ and the EQ-5D-5L scores (Fig. 4, C and D;
to EQ-5D-5L descriptive system score: r¼ 0.27,
p¼ 0.002; to EQ-5D-5L VAS: r¼ 0.25, p¼ 0.004).
DISCUSSION
Here, we translated the ZCMEI-21 questionnaire into
the Italian language, i.e., the ZCMEI-21-It, and validated
the ZCMEI-21-It in a prospective multicenter study. The
ZCMEI-21-It is the first Italian instrument that compre-
hensively assesses relevant symptoms and dimensions of
HRQoL in Italian-speaking patients affected by COM.
In current clinical practice, HRQoL in patients with
COM in Italian-speaking countries is measured using a
generic questionnaire called the Short Form 36 Health
Survey, validated in the Italian language in 1998 (29).
TABLE 2. Single item descriptive statistics of the ZCMEI-21-
It
Mean Min–Max ITC
Ear signs and symptoms
Ear pain 1.05 0–4 0.50
Discharge 1.26 0–4 0.43
Itching 1.06 0–4 0.49
Feeling of pressure 1.24 0–4 0.59
Balance 0.91 0–4 0.50
Hearing
Tinnitus 1.65 0–4 0.50
Hearing (filter question) 1.66 0–4 0.14
When many people speak
at the same time
1.37 0–4 0.21
Telephone, alarm-clock 1.49 0–4 0.17
Fear of not hearing other people 1.40 0–4 0.36
Psychosocial impact
Impact of ear symptoms
on HRQoL
2.11 0–4 0.53
Protection from water 1.45 0–4 0.47
Activities with family and friends 1.49 0–4 0.57
In public (e.g., occupation,
shopping)
1.55 0–4 0.51
Making contact with other people 1.07 0–4 0.56
Quality of sleep 1.65 0–4 0.63
Sadness 2.47 0–4 0.41




Medical consultations 1.18 0–4 0.45
Antibiotics (oral) 0.84 0–4 0.46
Ear drops 0.93 0–4 0.50
ITC item-total-correlation, min lowest value, max highest value;
answers to the ZCMEI-21-It are presented using a five-point scale
ranging from 0 (no emotional or physical impact) to 4 (severe
emotional or physical impact).
ZCMEI-21 indicates zurich chronic middle ear inventory.
TABLE 1. Demographics and clinical characteristics of the
patients
Validation Cohort (n¼ 128)
Males—no. (%) 69 (53.9%)
Females—no. (%) 59 (46.1%)
Age ( SD) 54.1 19.0 yr
COM, type—no. (%)
COM without cholesteatoma 79 (61.7%)
COM with cholesteatoma 49 (38.3%)




Previous surgery for COM—no. (%)
Had previous surgery 54 (42.2%)
No previous surgery 74 (57.8%)
COM indicates chronic otitis media.
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FIG. 2. A, Frequency distribution of the ZCMEI-21-It (bin width on x axis: 4). B, C, Comparison of ZCMEI-21-It total scores between
preoperative and postoperative patients with COM (B) and between patients suffering from COM with and without cholesteatoma (C).
Unpaired t test, whiskers indicates standard deviation range, bold horizontal line represents mean. COM indicates chronic otitis media;
ZCMEI-21, zurich chronic middle ear inventory.







































































r = 0.30, p = 0.008
A B C
FIG. 3. A,Correlation forZCMEI-21-It total scoresand thequestion#22,whichdirectlyassessedHRQoL(0on thexaxis: no impactonHRQoL
in question #22; 4 on the x axis: huge impact on HRQoL in question #22; Spearman rank correlation). B, C, Correlation between ZCMEI-21-It
total scoreandEQ-5D-5Ldescriptivesystemsscore (B)aswell as theEQ-5D-5LVAS (C). Solid line indicates linear regression line, dashed lines
indicates 95% prediction interval, r, Spearman’s rank correlation coefficient. ZCMEI-21 indicates zurich chronic middle ear inventory; HRQoL,
health-related quality of life; EQ-5D-5L, EuroQol five-dimensional questionnaire in its five-level version; VAS, visual analog scale.





ZCMEI-21-It/ZCMEI-21 total score ( SD) 29.8 14.6 29.7 16.1
Ear signs and symptoms 5.5 4.5 5.1 3.9
Hearing 7.6 5.1 8.5 5.2
Psychosocial impact 13.7 7.8 13.1 7.9
Medical resources 2.9 2.7 3.0 2.3
EQ-5D-5L ( SD)
Descriptive system score 0.84 0.15 0.92 0.14
VAS score 76.6 15.0 NA
Total score correlation (a)
To question directly assessing HRQoL r¼ 0.62, p< 0.0001 r¼ 0.74, p< 0.0001
To EQ-5D-5L descriptive system score r¼ 0.39, p< 0.0001 r¼ 0.60, p< 0.0001
Spearman’s rank correlation coefficient, p value.
ZCMEI-21 indicates zurich chronic middle ear inventory; EQ-5D-5L, EuroQol five-dimensional questionnaire in its five-level version; VAS,
visual analog scale.
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FIG. 4. Spearman rank correlation between ZCMEI-21-It subscale scores and EQ-5D-5L scores (descriptive system score and VAS).
Solid line represents linear regression line, dashed lines represent 95% prediction interval, r, Spearman’s rank correlation coefficient.
ZCMEI-21 indicates zurich chronic middle ear inventory; EQ-5D-5L, EuroQol five-dimensional questionnaire in its five-level version; VAS,
visual analog scale.
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However, Short Form 36 Health Survey has proven not to
be sensitive enough for the COM condition (15). To
compensate for this lack, a more specific questionnaire
for COM, the CES questionnaire, has been recently
translated and validated in Italian (CES-I) (20). The
CES-I proved to be a valid, disease-specific health
measure that can be used to evaluate adult patients with
COM among the Italian-speaking population (20). How-
ever, the CES-I primarily focuses on disease-specific
health and lacks specific assessment of the impact of
single symptoms on the QoL. Although the ZCMEI-21 is
partially based on the CES questionnaire, it differs in
several relevant aspects and has multiple advantages as it
has been developed to overcome the above limitations of
the CES and other questionnaires (19). Therefore, the use
of the ZCMEI-21 questionnaire in Italian language
patients may be a useful tool to be applied and may also
be used in conjunction with the CES-I questionnaire.
The translation of the ZCMEI-21 questionnaire in the
Italian language followed a standardized approach
involving both patients and clinicians. In the validation
process, we assessed the reliability and validity of the
ZCMEI-21-It. We found an excellent Cronbach’s a,
which provides evidence of the questionnaire’s reliabil-
ity. As expected, only moderate correlation between the
EQ-5D-5L and the ZCMEI-21-It total score was found.
In particular, weak to moderate correlations were found
for the ear signs and symptoms subscale as well as the
psychosocial impact subscale. This data provide evi-
dence that the ZCMEI-21-It in fact measures the complex
construct of HRQoL; yet it also underscores the fact that
generic questionnaires generally are less reliable in
assessing HRQoL in specific conditions. The EQ-5D-
5L constitutes a generic HRQoL questionnaire and does
therefore not meet the requirements of assessing detailed
HRQoL in specific diseases, such as COM (30). Inter-
estingly, no correlation could be found between the
ZCMEI-21-It subscale score of ‘‘hearing’’ and the
EQ-5D-5L, meaning that the patient’s subjective hearing
ability does not well correlate to the perceived HRQoL in
COM. Similar findings have also been demonstrated in
other studies (30,31). This may further corroborate the
application of specific PROMs in COM which do not
only account for hearing impairment as the sole factor
affecting HRQoL.
The cohort included in the present validation study
included both patients that already underwent surgery for
COM and patients that did not undergo surgery. Further-
more, both types of COM, i.e., COM with and without
cholesteatoma, were included. This is similar to the
cohort of the original ZCMEI-21 study, as the question-
naire has been developed to evaluate both pre- and
postoperative HRQoL in patients with both COM with
and without cholesteatoma. Thus, the ZCMEI-21 and its
translations are suited for research purposes as well as for
application in the clinical routine for the entire spectrum
of COM and both pre- and postoperatively.
In the present study, an article-based version of the
ZCMEI-21-It has been used. In contrast, the original
ZCMEI-21 was developed as an electronic questionnaire
delivered on a tablet computer. Yet, similar results are
expected in article-based and electronic application of
questionnaires (32). Therefore, the use of both article-
based and electronic versions of the ZCMEI-21-It is
justified based on the present validation data.
CONCLUSION
In the present article, we undertook an Italian transla-
tion of the ZCMEI-21 questionnaire according to stan-
dardized guidelines. In the subsequent validation study,
we acquired ample evidence demonstrating that the
ZCMEI-21-It is a reliable and valid questionnaire.
Hence, this new Italian-language questionnaire can be
used to quantify HRQoL in COM in both patients with
and without cholesteatoma, and regardless of whether
they had undergone surgery for COM.
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